Determination of sulpiride in pharmaceutical preparations and biological fluids using a Cr (III) enhanced chemiluminescence method

Luminescence

Volumn 28, Issue 6, 2013, Pages 915-921

  Khan, Muhammad Naeem ^a,b   Jan, Muhammad Rasul ^a   Shah, Jasmin ^a   Lee, Sang Hak ^b,c   Kim, Young Ho ^b  

^a UNIVERSITY OF PESHAWAR   (Pakistan)

^b Kyungpook National University   (South Korea)

^c Korea Basic Science Institute (KBSI)   (South Korea)

Author keywords

chemiluminescence; Cr (III); luminol; spiked human plasma; sulpiride

Indexed keywords

CHROMIUM COMPOUNDS; METAL IONS; PLASMA (HUMAN);

BIOLOGICAL FLUIDS; CHEMILUMINESCENCE INTENSITY; CR (III); ENHANCED CHEMILUMINESCENCES; LUMINOLS; PHARMACEUTICAL PREPARATIONS; SENSITIVE METHOD; SIMPLE METHOD; SPIKED HUMAN PLASMAS; SULPIRIDE;

CHEMILUMINESCENCE;

CHROMIUM; DRUG; HYDROGEN PEROXIDE; LUMINOL; SULPIRIDE;

ARTICLE; BODY FLUID; CHEMISTRY; CHEMOLUMINESCENCE; CR (III); HUMAN; LUMINESCENCE; SPIKED HUMAN PLASMA;

CHEMILUMINESCENCE; CR (III); LUMINOL; SPIKED HUMAN PLASMA; SULPIRIDE;

BODY FLUIDS; CHROMIUM; HUMANS; HYDROGEN PEROXIDE; LUMINESCENT MEASUREMENTS; LUMINOL; PHARMACEUTICAL PREPARATIONS; SULPIRIDE;

EID: 84890557116     PISSN: 15227235     EISSN: 15227243     Source Type: Journal    
DOI: 10.1002/bio.2458     Document Type: Article

References (37)

1. Reynolds JEF,. The extra pharmacopoeia. London: Royal Pharmaceutical Society of Great Britain, 1993: 375-6.
2. Huang MC, Ho HO, Yeh GC, Ke WT, Lin LC, Hsu TMB, et al,. Development of a high-performance liquid chromatographic method for bioanalytical applications with sulpiride. J Chromatogr B 2001; 763: 157-63.
3. Wiesel FA, Alfredsson G, Ehrnebo M, Sedvall G,. The pharmacokinetics of intravenous and oral sulpiride in healthy human subjects. Eur J Clin Pharmacol 1980; 17: 385.
4. Gorazza GR, Tonini M,. Levosulpiride for dyspepsia and emesis. A review of its pharmacology, efficacy and tolerability. Clin Drug Invest 2000; 19: 151-62.
5. Bressolle F, Bres J, Blanchin MD, Gomeni R,. Sulpiride pharmacokinetics in humans after intramuscular administration at three dose levels. J Pharm Sci 1984; 73: 1128-36.
6. Balant-Gorgia AE, Balant L,. Antipsychotic drugs: clinical pharmacokinetics of potential candidates for plasma concentration monitoring. Clin Pharmacokinet 1987; 13: 65-90.
7. Ji YP, Gao, CF,. Jian shu shu bi li de bu liang fan ying. Sichuan Mental Health 2006; 19: 63.
8. Staveris S, Jung L, Jamet G, Koffel JC,. Quantitative analysis of veralipride in plasma and urine by gas chromatography-mass spectrometry and gas chromatography with flame-ionization detection. J Chromatogr 1985; 338: 79-88.
9. Frigerio A, Pantarotto C,. Quantitative determination of sulpiride in biological samples from rats by gas-liquid chromatography and chemical ionization-mass fragmentography. J Chromatogr 1977; 130: 361-7.
10. Abdelal A, El-Enany N, Fathalla B,. Simultaneous determination of sulpiride and its alkaline degradation product by second derivative synchronous fluorescence spectroscopy. Talanta 2009; 80: 880-8.
11. Walash M, El-Din MS, El-Enany N, Eid M, Shalan S,. First derivative synchronous fluorescence spectroscopy for the simultaneous determination of sulpiride and mebeverine hydrochloride in their combined tablets and application to real human plasma. J Fluores 2010; 20: 1275-85.
12. Norman TR, James RH, Gregory MS,. Determination of tiapride in plasma by high performance liquid chromatography. J Chromatogr B 1986; 375: 197-201.
13. Bressolle F, Bres J,. Determination of sulpiride and sultopride by high-performance liquid chromatography for pharmacokinetic studies. J Chromatogr 1985; 341: 391-9.
14. Verbiese-Gtnard N, Hanocq M, Molle L,. High performance liquid chromatographic determination of sulpiride (Dogmatil) in urine. J Pharm Belg 1980; 35: 24-30.
15. Alfredsson G, Sedvall G, Wiesel FA,. Quantitative analysis of sulpiride in body fluids by high-performance liquid chromatography with fluorescence detection. J Chromatogr B 1979; 164: 187-93.
16. Nicolas P, Fauvelle F, Ennachachibi A, Merdjan H, Petitjean O,. Improved determination of sulpiride in plasma by ion-pair liquid chromatography with fluorescence detection. J Chromatogr 1986; 381: 393-400.
17. Musenga A, Mandrioli R, Morganti E, Fanali S, Raggi MA,. Enantioselective analysis of amisulpiride in pharmaceutical formulations by means of capillary electrophoresis. J Pharm Biomed Anal 2008; 46: 966-70.
18. Li J, Zhao F, Ju H,. Simultaneous electrochemiluminescence determination of sulpiride and tiapiride by capillary electrophoresis with cyclodextrin additives. J Chromatogr B 2006; 835: 84-9.
19. Farghaly OA,. Adsorptive stripping voltammetric of the antidepressant drug sulpiride. J Pharm Biomed Anal 2000; 23: 783-91.
20. Aly FA, Alarfaj NA, Alwarthan AA,. Flow injection chemiluminometric analysis of some benzamides by their sensitizing effect on the cerium-sulphite reaction. Talanta 2001; 54: 715-25.
21. 4-Tween 80 reaction. J Chin Chem Soc 2009; 56: 164-8.
22. Garcia-Campana AM, Baeyens WR,. Chemiluminescence in analytical chemistry. New York: Marcel Dekker, 2001.
23. Zhang YF, Cai XL, Yu JS, Ju HX,. Flow injection chemiluminescence analysis for highly sensitive determination of noscapine. J Photochem Photobiol A Chem 2004; 162 457-62.
24. Townshend A, Murillo-Pulgarin JA, Alanon-Pardo MT,. Flow injection chemiluminescence determination of propranolol in pharmaceutical preparations. Anal Chim Acta 2003; 488: 81-8.
25. Kamruzzaman M, Ferdous T, Alam AM, Lee SH, Kim SY, Kim YH, et al. A metal enhanced flow-injection chemiluminescence method for the rapid determination of norfloxacin in pharmaceutical formulations and serum sample. Bull Korean Chem Soc 2011; 32: 639. DOI 10.5012/bkcs.2011.32.2.639
26. 2 system. Sensor Lett 2011; 9: 518-25.
27. Hanaoka S, Lin JM, Yamada M,. Chemiluminescence behavior of the decomposition of hydrogen peroxide catalyzed by copper (II)-amino acid complexes and its application to the determination of tryptophan and phenylalanine. Anal Chim Acta 2000; 409: 65-73.
28. Burdo TG, Seitz WR,. Mechanism of cobalt catalysis of luminol chemiluminescence. Anal Chem 1975; 47: 1639-43.
29. Meng H, Wu F, He Z, Zeng Y,. Chemiluminescence determination of sulfite in sugar and sulfur dioxide in air using Tris(2,2'-bipyridyl)ruthenium (II)-permanganate system. Talanta 1999; 48: 571-7.
30. Yildiz G, Demiryurek AT,. Ferrous iron-induced luminol chemiluminescence: a method for hydroxyl radical study. J Pharmacol Toxicol 1998; 39: 179-84.
31. Parejo I, Petrakis C, Kefalas P,. A transition metal enhanced luminol chemiluminescence in the presence of a chelator. J Pharmacol Toxicol 2000; 43: 183-90.
32. Engelmann MD, Bobier RT, Hiatt T, Cheng IF,. Variability of the Fenton reaction characteristics of the EDTA, DTPA, and citrate complexes of iron. Biometals 2003; 16: 519-27.
33. Funahashi S, Funada S, Inamo M, Kurita R, Tanaka M,. Kinetic studies of the reactions of hydrogen peroxide with aqua (nitrilotriacetato) oxovanadate(IV) and diaquaoxo(2,6-pyridinedicarboxylato)vanadium(IV) in acidic aqueous solution. Inorg Chem 1982; 21: 2202-05.
34. Mochida I, Takeshita K,. Transition metal ions on molecular sieves. II. Catalytic activities of transition metal ions on molecular sieves for the decomposition of hydrogen peroxide. J Phys Chem 1974; 78: 1653-7.
35. Augusti R, Dias AO, Rocha LL, Lago RM,. Kinetics and mechanism of benzene derivative degradation with Fenton's reagent in aqueous medium studied by MIMS. J Phys Chem 1998; 102: 10723-7.
36. Mottola HA, Perez-Bendito D,. Kinetic determinations and some kinetic aspects of analytical chemistry. J Anal Chem 1996; 68: 257R-89R.
37. Xiao CB, King DW, Palmer DA, Wesolowski DJ,. Study of enhancement effects in the chemiluminescence method for Cr (III) in the ng 1(-1) range. Anal Chim Acta 2000; 415: 209-19.